PharmaCielo Signs Exclusive Agreement with Cooperativa Caucannabis
PharmaCielo has signed an exclusive agreement with Cooperativa Caucannabis to jointly cultivate in the historic cannabis producing region...
PharmaCielo
Echelon to advise PharmaCielo on Colombian cannabis exports
Echelon Wealth Partners Inc. has been retained to provide equity financing advisory services to PharmaCielo Ltd. PharmaCielo Ltd....
PharmaCielo seeks to minimize environmental impact in Colombia
PharmaCielo Ltd. President and CEO Dr. Patricio Stocker is pleased to announce two key initiatives designed to ensure...
Pritesh Kumar, PhD Engaged as Chief Scientific Officer by PharmaCielo Ltd.
TORONTO, Oct. 14, 2016 /CNW/ - PharmaCielo Ltd. is pleased to announce that Dr. Pritesh Kumar has accepted appointment to the position of Chief Scientific Officer for the company, effective immediately. Dr. Kumar is a research scientist with a specialization in cannabinoid pharmacology and will be responsible for leading PharmaCielo's research activities and partnerships globally.